Related Experiment Videos
Natural human interferon-alpha inhibits the adhesion of a human carcinoma cell line to human vascular endothelium
1Fujisaki Institute, Hayashibara Biochemical Laboratories, Inc., Okayama, Japan.
Abstract:
The adhesion of cells to the microvascular endothelium is an essential step in the inflammatory response and metastasis. We have found that pretreatment of a human epidermoid carcinoma cell line, KB, with natural human interferon-alpha (IFN-alpha) inhibited the binding of the malignant cells to human umbilical vein endothelial cells (HUVEC) in a dose- and time-dependent manner. As one of several possible mechanisms for this inhibition, the expression of some revelant adhesion molecules on KB cell surfaces was examined after IFN-alpha treatment. Apart from a slight increase in the expression of integrin alpha 4 beta 1 (very late activation antigen 4, VLA-4), no changes in the expression of other adhesion molecules, such as sialyl Lewis X, CD44, and leukocyte function-associated antigen 1 (LFA-1), which is known to be a heterodimer of CD11a and CD18, were observed after treatment with IFN-alpha. In addition, the cell viability of KB was not affected by treatment of the cells with IFN-alpha, although the cell proliferation was markedly inhibited, indicating that the inhibitory effect of IFN-alpha on KB cell binding to vascular endothelium is not a result of a cytotoxic effect of IFN-alpha. Because the metastatic process requires not only the adhesion of tumor cells to vascular endothelium during their extravasation but also proliferation at distant sites, our findings from this in vitro experimental model suggest that IFN-alpha may have a potential inhibitory effect on tumor cell metastasis.
Insights
Human interferon-alpha (IFN-alpha) inhibits cancer cell binding to endothelial cells, a key step in metastasis. This effect is not due to cell death, suggesting IFN-alpha
Area of Science:
- Cell Biology
- Immunology
- Oncology
Background:
- Cell adhesion to microvascular endothelium is crucial for inflammation and cancer metastasis.
- Understanding molecular mechanisms of cell adhesion is vital for developing anti-metastatic therapies.
Purpose of the Study:
- To investigate the effect of human interferon-alpha (IFN-alpha) on the binding of epidermoid carcinoma cells (KB) to human umbilical vein endothelial cells (HUVEC).
- To explore the role of adhesion molecules in IFN-alpha-mediated inhibition of tumor cell adhesion.
Main Methods:
- KB cells were pretreated with natural human IFN-alpha.
- Cell binding assays were performed between treated KB cells and HUVEC.
- Expression levels of adhesion molecules (VLA-4, sialyl Lewis X, CD44, LFA-1) on KB cells were analyzed post-IFN-alpha treatment.
- Cell viability and proliferation assays were conducted.
Main Results:
- IFN-alpha significantly inhibited KB cell binding to HUVEC in a dose- and time-dependent manner.
- A slight increase in integrin alpha 4 beta 1 (VLA-4) expression was observed, with no significant changes in sialyl Lewis X, CD44, or LFA-1.
- IFN-alpha inhibited KB cell proliferation but did not affect cell viability.
Conclusions:
- IFN-alpha effectively reduces tumor cell adhesion to endothelial cells.
- The mechanism involves modulation of specific adhesion molecules and inhibition of proliferation, not cytotoxicity.
- IFN-alpha shows potential as an anti-metastatic agent by disrupting tumor cell extravasation and proliferation at distant sites.